Regranex gel, a new biotech drug for diabetic foot ulcers

February 1998

Ortho-McNeil is now marketing Regranex gel, a new biotech drug for diabetic foot ulcers.

It contains becaplermin...a platelet-derived growth factor to stimulate the growth of new tissue. It's also being tested for nondiabetic ulcers and pressure sores.

The gel is applied once a day...for up to 20 weeks.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

How to reduce GI bleeding and ulcers in patients taking NSAIDs
Arthrotec, the new combination of diclofenac and misoprostol
Antibiotics Trovan (trovafloxacin), a very broad-spectrum quinolone
Antibiotics Two new antibiotic EAR drops will soon hit the market
Women's Health How much estrogen is enough to prevent bone loss?
Infectious Diseases New strain that's NOT in the current vaccine
Infectious Diseases New recommendations for immunizing health care workers
Withdrawal symptoms when patients stop taking Effexor or Effexor XR (venlafaxine)
Excedrin Migraine, the first OTC approved specifically for migraines
Pediatrics Rocephin is now officially approved for acute otitis media
Diabetes Mexitil (mexiletine) for persistent diabetic neuropathy
Diabetes Another new drug for type 2 diabetes, called Prandin (repaglinide)
Diabetes Chromium for diabetes
Dermatology Regranex gel, a new biotech drug for diabetic foot ulcers
Dermatology Bactroban now comes as a CREAM
Coenzyme Q-10 (Co Q-10)
STIs New STD treatment guidelines

Regranex gel, a new biotech drug for diabetic foot ulcers

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents